Q&A with Oncimmune CEO, Martin Gouldstone
Episode 1718, Nov 24, 2023, 01:43 PM
(Watch the video interview HERE)
In this interview, CEO Martin Gouldstone of Oncimmune (ONC) - a global leader in immune biomarkers and immunodiagnostics – takes Vox Markets through:
00:00 His first impressions of the business & how ONC's services are used in the field.
07:00 Revised commercial strategy
17:45 Current health of the sector
21:20 Size of the addressable market
28:55 Roadmap & timelines ahead
In this interview, CEO Martin Gouldstone of Oncimmune (ONC) - a global leader in immune biomarkers and immunodiagnostics – takes Vox Markets through:
00:00 His first impressions of the business & how ONC's services are used in the field.
07:00 Revised commercial strategy
17:45 Current health of the sector
21:20 Size of the addressable market
28:55 Roadmap & timelines ahead